Otsuka Wins Appeal Ruling Upholding Abilify Drug Patent

Otsuka Holdings’ pharmaceutical unit and partner Bristol-Myers Squibb won an appeals court ruling that will help ward off generic-drug competition to their schizophrenia drug Abilify until April 2015.
Businessweek